Potassium channel blockade and acute myocardial infarction: implications for management of the non-insulin requiring diabetic patient.
Hofmann
D
D
Opie
L H
LH
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004285:Dogs; D005905:Glyburide / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D009203:Myocardial Infarction / Q000209:etiology / Q000503:physiopathology*; D011188:Potassium / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects* / Q000502:physiology; D011817:Rabbits; D051381:Rats; D014661:Vasoconstriction / Q000187:drug effects
D007004:Hypoglycemic Agents; D007328:Insulin; D015221:Potassium Channels; D000255:Adenosine Triphosphate; D011188:Potassium; D005905:Glyburide